Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Pediatric Endocrinology · Congenital lipoid adrenal hyperplasia due to STAR deficiency

Daily Management: Balancing Your Child's Hormones

At a Glance

Children with STAR deficiency need carefully timed hydrocortisone and, when needed, fludrocortisone and prescribed salt. Doctors adjust treatment using growth, energy, blood pressure, and salt and potassium tests rather than trying to normalize ACTH alone.

Managing Lipoid Congenital Adrenal Hyperplasia (LCAH) requires a precise balance of replacement hormones. Because your child’s body cannot adequately produce its own cortisol or aldosterone, the goal of daily treatment is to mimic the body’s natural rhythms as closely as possible while avoiding the side effects of too much medication [1][2].

Medication Overview Table

Medicine Purpose Routine Timing What to Do if Missed/Vomited Who to Call
Hydrocortisone Replaces Cortisol 3–4 times daily, per clinician Check sick day plan; may need injection Clinic / 911 if crisis
Fludrocortisone Replaces Aldosterone Usually 1–2 times daily Follow clinician instructions Clinic
Sodium Chloride Maintains Salt Exactly as prescribed Follow clinician instructions Clinic

Glucocorticoid Replacement (Hydrocortisone)

The most critical part of daily therapy is replacing cortisol. In children, hydrocortisone is the preferred medication because it is short-acting and less likely to interfere with natural growth than longer-acting steroids [2][3].

  • Dosing Schedule: Hydrocortisone is typically given in three or four doses throughout the day to keep hormone levels stable [2][4]. A common strategy is to give the largest dose first thing in the morning [5], though this varies.
  • Target Doses: Maintenance doses vary widely based on age, body size (body surface area), residual STAR function, and clinical findings. For example, a classic illustrative range might start around 8 to 10 mg/m²/day, but this is not a universal prescription [2][6]. Never change or withhold hydrocortisone based on a single laboratory value without the endocrine team.
  • The Growth Balance: Your doctor will monitor your child’s growth velocity (how fast they are growing) very closely. If the dose is too low, the child may experience low energy or “adrenal crises”; if it is too high, it can lead to weight gain and slowed height growth [2][3].

Mineralocorticoid and Salt Replacement

Because STAR deficiency also affects the body’s ability to balance salt and water, many children—especially those with the classic form—require two additional supplements:

  1. Fludrocortisone: This medication replaces aldosterone. It helps the kidneys hold onto sodium and get rid of excess potassium [7]. It is usually taken once or twice daily.
  2. Sodium Chloride (Salt) Supplementation: Infants, in particular, often need liquid salt added to their formula or breast milk because their kidneys are less efficient at processing fludrocortisone [8]. This must be measured exactly as prescribed.

Monitoring Success

Unlike some conditions where one blood test tells the whole story, monitoring LCAH requires looking at several markers together.

  • Electrolytes: Frequent blood tests will check levels of sodium and potassium.
  • Plasma Renin Activity (PRA): Renin is a hormone that rises when the body is “thirsty” for more salt or mineralocorticoid. In LCAH, doctors often aim for renin levels to be in the upper-normal range, though targets are individualized [7][9].
  • Blood Pressure: Regular blood pressure checks help ensure the fludrocortisone dose isn’t causing hypertension (high blood pressure) [9][10].

The “ACTH Trap”

One of the most important things for parents to understand is why ACTH (Adrenocorticotropic Hormone) should not be chased in isolation.

In a healthy body, ACTH tells the adrenals to work. In STAR deficiency, because the adrenals cannot respond adequately, ACTH levels can become very high [11]. ACTH often remains high even when a child is well treated [11][12].

It is a common mistake to think hydrocortisone doses must be increased simply to bring the ACTH level down. Pursuing a “normal” ACTH level often results in giving the child far more steroid than their body needs, which can lead to stunted growth, unhealthy weight gain, and weakened bones [2][13].

Instead of changing doses based on a single ACTH number, your care team will interpret it alongside medication adherence, dose timing, energy levels, growth charts, electrolytes, and renin [8][14]. Your role is to provide the consistent, timed dosing that keeps these levels stable day-to-day.

Common questions in this guide

What daily medicines are used for children with STAR deficiency?
Hydrocortisone replaces cortisol. Fludrocortisone replaces aldosterone, and some children—especially infants with the classic form—also need precisely measured sodium chloride or salt supplementation. The child's endocrinology team determines the schedule and doses.
Why is hydrocortisone divided into several doses each day?
Hydrocortisone is short-acting, so it is usually given three or four times daily to keep cortisol replacement more stable and approximate the body's normal rhythm. The largest dose may be given in the morning, but the exact schedule varies by child.
What should I do if my child misses or vomits a hydrocortisone dose?
Follow your child's written sick-day plan and contact the endocrine clinic for instructions. Vomiting or an adrenal crisis may require an emergency hydrocortisone injection; call emergency services if your child is seriously unwell or the plan directs you to do so. Do not change or withhold doses on your own.
Can ACTH remain high even when LCAH treatment is working?
Yes. In STAR deficiency, the adrenal glands cannot respond normally, so ACTH may stay high even when the child is clinically well and receiving appropriate treatment. Doctors interpret ACTH with growth, energy, dose timing, adherence, electrolytes, and renin rather than increasing hydrocortisone to normalize ACTH alone.
How do doctors know whether hormone replacement is properly balanced?
They look at the child's growth rate, energy, medication timing and adherence, sodium and potassium levels, plasma renin activity, and blood pressure together. Renin is often targeted to an individualized upper-normal range, while blood pressure helps detect too much fludrocortisone. No single test determines the correct dose.
What are signs that my child may be receiving too much or too little hydrocortisone?
Too little replacement can cause low energy and increase the risk of an adrenal crisis, while too much can cause weight gain and slowed height growth. The care team uses growth charts, symptoms, dose history, and laboratory results to assess the dose. Contact the clinician before changing medication.

Get notified when new evidence is published on Congenital lipoid adrenal hyperplasia due to STAR deficency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Adrenal Crisis in an Adult Patient With Lipoid Congenital Adrenal Hyperplasia due to STAR Protein Mutation.

    Zavgorodneva Z, Kaljevic M, Chen K

    AACE endocrinology and diabetes 2026; (13(5)):788-791 doi:10.1016/j.aed.2026.04.016.

    PMID: 42978993
  2. 2

    Treatment and Follow-up of Non-stress Adrenal Insufficiency

    Buğrul F, Özcan Murat N

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):93-101 doi:10.4274/jcrpe.galenos.2024.2024-6-23-S.

    PMID: 39713906
  3. 3

    Growth alterations in rare forms of primary adrenal insufficiency: a neglected issue in paediatric endocrinology.

    Ferrigno R, Cioffi D, Pellino V, et al.

    Endocrine 2023; (80(1)):1-9 doi:10.1007/s12020-022-03236-z.

    PMID: 36309634
  4. 4

    Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German/Austrian registry.

    Hoyer-Kuhn H, Huebner A, Richter-Unruh A, et al.

    Endocrine connections 2021; (10(5)):561-569.

    PMID: 33909597
  5. 5

    Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.

    Melin J, Parra-Guillen ZP, Michelet R, et al.

    The Journal of clinical endocrinology and metabolism 2020; (105(3)) doi:10.1210/clinem/dgaa071.

    PMID: 32052005
  6. 6

    International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry.

    Bacila I, Freeman N, Daniel E, et al.

    European journal of endocrinology 2021; (184(4)):553-563.

    PMID: 33460392
  7. 7

    Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy.

    Esposito D, Pasquali D, Johannsson G

    The Journal of clinical endocrinology and metabolism 2018; (103(2)):376-387 doi:10.1210/jc.2017-01928.

    PMID: 29156052
  8. 8

    Two siblings with lipoid congenital adrenal hyperplasia: first reported case in Serbia and literature review.

    Jesic MD, Kovacevic S, Zdravkovic V, et al.

    Frontiers in endocrinology 2026; (17()):1912249 doi:10.3389/fendo.2026.1912249.

    PMID: 42688021
  9. 9

    Plasma Renin Measurements are Unrelated to Mineralocorticoid Replacement Dose in Patients With Primary Adrenal Insufficiency.

    Pofi R, Prete A, Thornton-Jones V, et al.

    The Journal of clinical endocrinology and metabolism 2020; (105(1)) doi:10.1210/clinem/dgz055.

    PMID: 31613957
  10. 10

    Renin and electrolytes indicate the mineralocorticoid activity of fludrocortisone: a 6 year study in primary adrenal insufficiency.

    Ceccato F, Torchio M, Tizianel I, et al.

    Journal of endocrinological investigation 2023; (46(1)):111-122 doi:10.1007/s40618-022-01889-1.

    PMID: 35947299
  11. 11

    A case report of pedigree of a homozygous mutation of the steroidogenic acute regulatory protein causing lipoid congenital adrenal hyperplasia.

    Fu R, Lu L, Jiang J, et al.

    Medicine 2017; (96(21)):e6994 doi:10.1097/MD.0000000000006994.

    PMID: 28538409
  12. 12

    Long-term follow-up in a Chinese child with congenital lipoid adrenal hyperplasia due to a StAR gene mutation.

    Zhao X, Su Z, Liu X, et al.

    BMC endocrine disorders 2018; (18(1)):78 doi:10.1186/s12902-018-0307-6.

    PMID: 30400872
  13. 13

    The Complex Spectrum of 11β-Hydroxylase Deficiency: A Case of Precocious Puberty, Hypertension, and Testicular Adrenal Rest Tumors (TARTs).

    Mangam NB, Deb P, Nalla S, et al.

    Cureus 2025; (17(10)):e94192 doi:10.7759/cureus.94192.

    PMID: 41209875
  14. 14

    A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.

    Neumann U, Braune K, Whitaker MJ, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(3)):e1433-e1440 doi:10.1210/clinem/dgaa626.

    PMID: 32888021

This page is for informational purposes only and does not constitute medical advice. Your child's pediatric endocrinology team must set medication doses, sick-day instructions, and monitoring targets.